Steve Oghumu

20PUBLICATIONS
26CO-AUTHORS
Tumour immunologyMolecular targetsSolid tumoursBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Aug 18, 2026
Myeloid-derived MIF is a central regulator of MDSC-driven T-cell dysfunction in head and neck squamous cell carcinoma.

|Jun 12, 2026
From Berry to Bedside: Translational Potential of Berry-Derived Phytochemicals in HNSCC.

|Dec 23, 2025
PI3Kγ inhibition drives M1 macrophage differentiation and synergizes with PD-L1 blockade to improve survival in poorly immunogenic head and neck squamous cell carcinoma.

Pete P Jordanides, Sushmitha Jagadeesha, Puja Upadhaya

|Oct 11, 2025
Durable Response to Pazopanib (Tyrosine Kinase Inhibitor) in a Patient With EWSR1::CREM Gene Fusion Positive Intra-Abdominal Unclassified Epithelioid Sarcoma.

Saba Shafi, Dan Jones, Xiaokang Pan

|Mar 18, 2025
Efficacy of anti-LAG3 and anti-PD-1 combination checkpoint inhibitor therapy against head and neck squamous cell carcinoma in a genetically engineered mouse model.

Felipe F Lamenza, Peyton Roth, Puja Upadhaya

|Jan 23, 2024
Berries vs. Disease: Revenge of the Phytochemicals.

Felipe F Lamenza, Puja Upadhaya, Peyton Roth

Pageof 4

Frequent Collaborators

4 joint publications

Nathan Ryan

2 joint publications

Greta Volpedo

1 joint publications

N Fatima

1 joint publications

N Sheikh